About this episode

The episode discusses Pfizer's mid-stage trial data for a GLP-1 therapy, McDonald's new AI drive-thru system, and the inclusion of Marvell Technology and Flex in the S&P 500.

Pfizer (PFE) says mid-stage trial data support monthly dosing for GLP-1 therapy. (00:13) Introducing Archy IQ: McDonald's (MCD) new AI drive-thru system. (01:03) Marvell Technology (MRVL), Flex (FLEX) jump on S&P 500 inclusion plan. Episode transcripts seekingalpha.com/wsb . Show links: Biggest stock movers Monday: NRIX, HON, and more Tech sell-off can be a buying opportunity, says Nvidia CEO Jensen Huang Strait of Hormuz to remain open but with transit fees, Iran envoy to Moscow quoted AI World Cup predictions: the machines love France Sign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions .

More episodes of Wall Street Breakfast

• Wall Street Roundup: Trillion dollar baby · June 12, 2026 · 11 min
• SpaceX enters public orbit · June 12, 2026 · 7 min
• No reward for Oracle's beat · June 11, 2026 · 5 min
• CPI eases rate fears · June 10, 2026 · 3 min
• Iran strikes hit futures · June 10, 2026 · 5 min
• AI job fears ease · June 9, 2026 · 4 min

Explore listener stats, chart rankings, contacts and more on the Wall Street Breakfast podcast page.